SCHEMBL21614778

SCHEMBL21614778

FC(F)(F)c1cc(SCc2nc3cc(Sc4ccccc4)ccc3[nH]2)ccn1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 8/20 0.48
▸ NPC1 O15118 6/20 0.48
▸ RAB9A P51151 6/20 0.48
▸ CYP1A2 P05177 2/20 0.48
▸ CYP2D6 P10635 2/20 0.48
▸ CYP2C9 P11712 2/20 0.48
▸ CYP3A4 P08684 1/20 0.48
▸ CYP2C19 P33261 1/20 0.48
▸ KMT2A Q03164 4/20 0.42
▸ ALDH1A1 P00352 4/20 0.42
▸ HPGD P15428 4/20 0.42
▸ MEN1 O00255 3/20 0.42
▸ POLB P06746 1/20 0.42
▸ PDE10A Q9Y233 1/20 0.41
▸ LMNA P02545 5/20 0.40
▸ TYMS P04818 2/20 0.38
▸ MAPT P10636 2/20 0.36
▸ HTT P42858 2/20 0.36
▸ KDM4E B2RXH2 3/20 0.35
▸ HSD17B10 Q99714 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21611983 0.84 PDE10A (0.48) SMN1; SMN2NPC1RAB9ACYP1A2CYP2D6
SCHEMBL23618336 0.84 NPC1 (0.44) SMN1; SMN2NPC1RAB9ACYP1A2CYP2D6
SCHEMBL21611980 0.83 NPC1 (0.48) SMN1; SMN2NPC1RAB9ACYP1A2CYP2D6
SCHEMBL30040677 0.83 NPC1 (0.40) SMN1; SMN2NPC1RAB9ACYP1A2CYP2D6
SCHEMBL25399746 0.83 NPC1 (0.40) SMN1; SMN2NPC1RAB9ACYP1A2CYP2D6
SCHEMBL30579946 0.83 NPC1 (0.40) SMN1; SMN2NPC1RAB9ACYP1A2CYP2D6
SCHEMBL30579945 0.83 NPC1 (0.40) SMN1; SMN2NPC1RAB9ACYP1A2CYP2D6
SCHEMBL24027541 0.82 SMN1; SMN2 (0.44) SMN1; SMN2NPC1RAB9ACYP1A2CYP2D6
SCHEMBL7801981 0.82 SMN1; SMN2 (0.60) SMN1; SMN2NPC1RAB9ACYP1A2CYP2D6
Hydrochloric Acid SCHEMBL8477873 0.81 SMN1; SMN2 (0.59) SMN1; SMN2NPC1RAB9ACYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020007938-A1 PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2020-01-09 — — WO disclosed
Send feedback